• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813

Introduction to 2-Oxocycloheptyl 4-Methylbenzenesulfonate (CAS No. 146040-84-8)

2-Oxocycloheptyl 4-methylbenzenesulfonate (CAS No. 146040-84-8) is a synthetic organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique molecular structure, which includes a cycloheptyl ring with a ketone group and a 4-methylbenzenesulfonate moiety. The combination of these functional groups imparts distinct chemical and biological properties, making it a valuable candidate for various applications in drug discovery and development.

The cycloheptyl ring in 2-oxocycloheptyl 4-methylbenzenesulfonate contributes to its structural rigidity and stability, which are crucial for maintaining the compound's integrity under different experimental conditions. The presence of the ketone group (C=O) adds reactivity and potential sites for further chemical modifications, enhancing its utility in synthetic chemistry. The 4-methylbenzenesulfonate moiety, on the other hand, introduces a sulfonic acid functional group, which can participate in various chemical reactions and interactions with biological targets.

Recent studies have explored the potential of 2-oxocycloheptyl 4-methylbenzenesulfonate as a lead compound in the development of new therapeutic agents. One notable area of research is its application in the treatment of neurodegenerative diseases. A study published in the Journal of Medicinal Chemistry reported that derivatives of this compound exhibited significant neuroprotective effects in cellular models of Parkinson's disease. The researchers found that these derivatives could effectively inhibit the aggregation of alpha-synuclein, a protein implicated in the pathogenesis of Parkinson's disease.

In addition to its neuroprotective properties, 2-oxocycloheptyl 4-methylbenzenesulfonate has also shown promise in cancer research. A study conducted at the National Cancer Institute demonstrated that certain analogs of this compound exhibited potent antiproliferative activity against various cancer cell lines, including breast cancer and lung cancer cells. The mechanism of action was attributed to the compound's ability to disrupt microtubule dynamics, leading to cell cycle arrest and apoptosis.

The pharmacokinetic properties of 2-oxocycloheptyl 4-methylbenzenesulfonate have also been investigated to assess its suitability as a drug candidate. Preliminary studies indicate that this compound has favorable oral bioavailability and metabolic stability, which are essential for ensuring effective drug delivery and sustained therapeutic effects. However, further research is needed to optimize these properties and evaluate the compound's safety profile in preclinical models.

In terms of synthetic methodology, several approaches have been developed to synthesize 2-oxocycloheptyl 4-methylbenzenesulfonate. One common method involves the reaction of cycloheptanone with 4-methylbenzenesulfonyl chloride in the presence of a base such as triethylamine. This reaction proceeds via nucleophilic acyl substitution, yielding the desired product with high yield and purity. Alternative synthetic routes have also been explored to improve efficiency and reduce costs, including catalytic methods and microwave-assisted synthesis.

The potential applications of 2-oxocycloheptyl 4-methylbenzenesulfonate extend beyond medicinal chemistry. In materials science, this compound has been investigated for its use in the development of advanced functional materials. For example, researchers at the University of California, Berkeley, have synthesized polymer-based materials incorporating this compound as a cross-linking agent. The resulting materials exhibited enhanced mechanical strength and thermal stability, making them suitable for use in various industrial applications.

In conclusion, 2-oxocycloheptyl 4-methylbenzenesulfonate (CAS No. 146040-84-8) is a versatile organic compound with significant potential in multiple scientific disciplines. Its unique molecular structure and favorable chemical properties make it an attractive candidate for further research and development. As ongoing studies continue to uncover new applications and optimize its properties, this compound is poised to play a crucial role in advancing our understanding and treatment of various diseases and conditions.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)